AMIC looks to down-classify brachytherapy's FDA status

Advanced Medical Isotope Corp. considers pursuing regulatory down-classification for its brachytherapy cancer product.

Washington-based Advanced Medical Isotope Corp. is evaluating its options for U.S. market approval of its proprietary brachytherapy cancer product, the company announced.

Advanced Medical Isotope Corp., Food & Drug Administration (FDA)

News Well, Regulatory/Clearance, Brachytherapy, Food & Drug Administration (FDA), Oncology, Pre-Market Approval (PMA), Radiosurgery

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/MoJhU4